Somatostatin receptor activity assessed by 68Ga-DOTATOC PET can preoperatively predict DAXX/ATRX loss of expression in well-differentiated pancreatic neuroendocrine tumors

被引：0
|
作者：
Paola Mapelli
Carolina Bezzi
Francesca Muffatti
Samuele Ghezzo
Francesco Baldassi
Marco Schiavo Lena
Valentina Andreasi
Carla Canevari
Patrizia Magnani
Francesco De Cobelli
Luigi Gianolli
Stefano Partelli
Massimo Falconi
Maria Picchio
机构：
[1] Vita-Salute San Raffaele University,Nuclear Medicine Department
[2] IRCCS San Raffaele Scientific Institute,Pancreatic Surgery Unit
[3] IRCCS San Raffaele Scientific Institute,Pathology Unit
[4] University of Milano-Bicocca,Department of Radiology
[5] IRCCS San Raffaele Scientific Institute,undefined
[6] IRCCS San Raffaele Scientific Institute,undefined
来源：
European Journal of Nuclear Medicine and Molecular Imaging | 2023年 / 50卷
关键词：
Ga-DOTA-peptides; Pancreatic neuroendocrine tumor; PET; Predictive value; DAXX; ATRX; Risk assessment; Preoperative; Somatostatin receptor activity;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2818 / 2829
页数：11
相关论文
共 50 条
  • [21] Prospective study of dynamic whole-body 68Ga-DOTATOC-PET/CT acquisition in patients with well-differentiated neuroendocrine tumors
    Thuillier, Philippe
    Bourhis, David
    Metges, Jean Philippe
    Le Pennec, Romain
    Amrane, Karim
    Schick, Ulrike
    Blanc-Beguin, Frederique
    Hennebicq, Simon
    Salaun, Pierre-Yves
    Kerlan, Veronique
    Karakatsanis, Nicolas
    Abgral, Ronan
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [22] Prognostic value of somatostatin receptor expressing tumor volume calculated from 68Ga-DOTATATE PET/CT in patients with well-differentiated neuroendocrine tumors
    Toriihara, Akira
    Baratto, Lucia
    Nobashi, Tomomi
    Park, Sonya
    Hatami, Negin
    Davidzon, Guido
    Kunz, Pamela L.
    Iagaru, Andrei
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (11) : 2244 - 2251
  • [23] Prognostic value of somatostatin receptor expressing tumor volume calculated from 68Ga-DOTATATE PET/CT in patients with well-differentiated neuroendocrine tumors
    Akira Toriihara
    Lucia Baratto
    Tomomi Nobashi
    Sonya Park
    Negin Hatami
    Guido Davidzon
    Pamela L. Kunz
    Andrei Iagaru
    European Journal of Nuclear Medicine and Molecular Imaging, 2019, 46 : 2244 - 2251
  • [24] 68Ga-DOTATATE PET/CT for the Early Prediction of Response to Somatostatin Receptor-Mediated Radionuclide Therapy in Patients with Well-Differentiated Neuroendocrine Tumors
    Haug, Alexander R.
    Auernhammer, Christoph J.
    Waengler, Bjoern
    Schmidt, Gerwin P.
    Uebleis, Christopher
    Goeke, Burkhard
    Cumming, Paul
    Bartenstein, Peter
    Tiling, Reinhold
    Hacker, Marcus
    JOURNAL OF NUCLEAR MEDICINE, 2010, 51 (09) : 1349 - 1360
  • [25] Prognostic value of whole-body PET volumetric parameters extracted from 68Ga-DOTATOC-PETICT in well-differentiated neuroendocrine tumors
    Thuillier, P.
    Liberini, V
    Grimaldi, S.
    Rampado, O.
    Gallo, E.
    De Santi, B.
    Ceci, F.
    Arvat, E.
    Piovesan, A.
    Filippi, R.
    Molinari, F.
    Deandreis, D.
    JOURNAL OF NEUROENDOCRINOLOGY, 2021, 33 : 198 - 198
  • [26] Preoperative assessment of lymph nodal metastases with [68Ga]Ga-DOTATOC PET radiomics for improved surgical planning in well-differentiated pancreatic neuroendocrine tumours
    Mapelli, Paola
    Bezzi, Carolina
    Muffatti, Francesca
    Ghezzo, Samuele
    Canevari, Carla
    Magnani, Patrizia
    Lena, Marco Schiavo
    Battistella, Anna
    Scifo, Paola
    Andreasi, Valentina
    Partelli, Stefano
    Chiti, Arturo
    Falconi, Massimo
    Picchio, Maria
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 (09) : 2774 - 2783
  • [27] First-in-human PET/CT Imaging of somatostatin receptor expressing tumors with the novel somatostatin receptor antagonist 68Ga-NODAGA-LM3-a comparison with 68Ga-DOTATOC PET/CT
    Singh, A.
    Kulkarni, H. R.
    Langbein, T.
    Mueller, D.
    Senftleben, S.
    Fani, M.
    Maecke, H.
    Baum, R. P.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 : S184 - S185
  • [28] 68Ga-DOTATOC PET/CT after 1 cycle of PRRT with 90Y-DOTATOC visualizes changes in somatostatin receptor availability in neuroendocrine tumours
    Van Binnebeek, S.
    Mottaghy, F. M.
    Koole, M.
    Baete, K.
    Vanbilloen, B.
    Terwinghe, C.
    Clement, P.
    Verbruggen, A.
    Mortelmans, L.
    Van Cutsem, E.
    Haustermans, K.
    Verslype, C.
    Deroose, C. M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2010, 37 : S367 - S367
  • [29] Progesterone Receptor Expression Is a Sensitive and Relatively Specific Biomarker for Well-Differentiated Pancreatic Neuroendocrine Tumors
    DeJulio, Todd
    You, Xiaoming
    Li, Haonan
    Liao, Jie
    Rao, Sambasiva
    Lin, Xiaoqi
    Yang, Guang-Yu
    MODERN PATHOLOGY, 2016, 29 : 148A - 148A
  • [30] Progesterone Receptor Expression Is a Sensitive and Relatively Specific Biomarker for Well-Differentiated Pancreatic Neuroendocrine Tumors
    DeJulio, Todd
    You, Xiaoming
    Li, Haonan
    Liao, Jie
    Rao, Sambasiva
    Lin, Xiaoqi
    Yang, Guang-Yu
    LABORATORY INVESTIGATION, 2016, 96 : 148A - 148A
12345